Copper in Gynecological Diseases
International Journal of Molecular Sciences · 17.12.2023 · 24 (24) · 17578
DOI: 10.3390/ijms242417578 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.12.2023. Verfasst von Rocío A Conforti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis (UNSL), Instituto Multidisciplinario de Investigaciones Biológicas de Sa…. Hauptthemen laut MEDLINE: Hepatolenticular Degeneration, Genital Diseases, Female, Diabetes Mellitus, Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 379 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina, Universidad Nacional de San Luis (UNSL), Argentina, Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT), Argentina.
Abstract (Originalsprache)
Copper (Cu) is an essential micronutrient for the correct development of eukaryotic organisms. This metal plays a key role in many cellular and physiological activities, including enzymatic activity, oxygen transport, and cell signaling. Although the redox activity of Cu is crucial for enzymatic reactions, this property also makes it potentially toxic when found at high levels. Due to this dual action of Cu, highly regulated mechanisms are necessary to prevent both the deficiency and the accumulation of this metal since its dyshomeostasis may favor the development of multiple diseases, such as Menkes’ and Wilson’s diseases, neurodegenerative diseases, diabetes mellitus, and cancer. As the relationship between Cu and cancer has been the most studied, we analyze how this metal can affect three fundamental processes for tumor progression: cell proliferation, angiogenesis, and metastasis. Gynecological diseases are characterized by high prevalence, morbidity, and mortality, depending on the case, and mainly include benign and malignant tumors. The cellular processes that promote their progression are affected by Cu, and the mechanisms that occur may be similar. We analyze the crosstalk between Cu deregulation and gynecological diseases, focusing on therapeutic strategies derived from this metal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis (UNSL), Instituto Multidisciplinario de Investigaciones Biológicas de San Luis (IMIBIO-SL-CONICET), San Luis CP D5700HHW, Argentina.
- Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, McGill University, 3775 University Street, Montreal, QC H3A 2B4, Canada.
- Cancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
ORCID-Profile: Rocío A Conforti, María B Delsouc, Carlos M Telleria
Förderung
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina
- Universidad Nacional de San Luis (UNSL), Argentina
- Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT), Argentina
- Health Canada to Ovarian Cancer Canada
- Government of Canada
Zitieren
APA
Conforti, R. A., Delsouc, M. B., Zorychta, E., Telleria, C. M., & Casais, M. (2023). Copper in Gynecological Diseases. International Journal of Molecular Sciences, 24(24), 17578. https://doi.org/10.3390/ijms242417578
Vancouver
Conforti RA, Delsouc MB, Zorychta E, Telleria CM, Casais M. Copper in Gynecological Diseases. International Journal of Molecular Sciences. 2023;24(24):17578. doi:10.3390/ijms242417578
BibTeX
@article{Conforti2023,
author = {Conforti, Rocío A and Delsouc, María B and Zorychta, Edith and Telleria, Carlos M and Casais, Marilina},
title = {Copper in Gynecological Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {24},
pages = {17578},
doi = {10.3390/ijms242417578}
}
EUVIMED